DOP45 Adequate infliximab exposure during the induction phase is associated with early complete fistula response in patients with fistulizing Crohn’s disease: a post-hoc analysis of the ACCENT-2 trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.